Literature DB >> 18355244

Differential and cell-type specific regulation of responses to Toll-like receptor agonists by ISO-1.

Peter W West1, Lisa C Parker, Jon R Ward, Ian Sabroe.   

Abstract

Macrophage migration inhibitory factor (MIF) plays vital roles in the regulation of responses to stimuli acting via Toll-like receptor (TLR)-4. Recently, a specific small molecule inhibitor of MIF (ISO-1) has been described. We investigated the effects of ISO-1 on TLR responses in primary human monocytes and monocyte-derived macrophages (MDM). In monocytes, ISO-1 caused marked suppression of TLR4-induced proinflammatory cytokine production, and to a lesser extent suppression of TLR2-induced responses. The lipopolysaccharide (LPS)-induced activation of cocultures of monocytes and endothelial cells was strongly inhibited by ISO-1. Suppression of monocyte TLR4 signalling by ISO-1 was associated with alterations in extracellular signal-related kinase (ERK)-1/2 activation status. Previously, regulation of TLR4 signalling by MIF has been noted to be through control of TLR4 expression, but we observed that the actions of ISO-1 were mediated without changes in cell surface TLR4 levels. In contrast, ISO-1 pretreatment did not inhibit responses of MDM to LPS. ISO-1 is a promising parent molecule which inhibits TLR-induced ERK activation and inflammatory cytokine production in monocytes, whose role may be complicated by cell-type specificity.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18355244      PMCID: PMC2526264          DOI: 10.1111/j.1365-2567.2008.02825.x

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  42 in total

Review 1.  Macrophage migration inhibitory factor: an emerging therapeutic target in rheumatoid arthritis.

Authors:  Eric F Morand; Richard Bucala; Michelle Leech
Journal:  Arthritis Rheum       Date:  2003-02

Review 2.  Functional plasticity of macrophages: reversible adaptation to changing microenvironments.

Authors:  Robert D Stout; Jill Suttles
Journal:  J Leukoc Biol       Date:  2004-06-24       Impact factor: 4.962

3.  Inhibition of macrophage migration inhibitory factor or its receptor (CD74) attenuates growth and invasion of DU-145 prostate cancer cells.

Authors:  Katherine L Meyer-Siegler; Kenneth A Iczkowski; Lin Leng; Richard Bucala; Pedro L Vera
Journal:  J Immunol       Date:  2006-12-15       Impact factor: 5.422

4.  The tautomerase active site of macrophage migration inhibitory factor is a potential target for discovery of novel anti-inflammatory agents.

Authors:  Jodi B Lubetsky; Angeles Dios; Jialian Han; Bayan Aljabari; Bela Ruzsicska; Robert Mitchell; Elias Lolis; Yousef Al-Abed
Journal:  J Biol Chem       Date:  2002-05-07       Impact factor: 5.157

5.  Toll-like receptor (TLR)2 and TLR4 in human peripheral blood granulocytes: a critical role for monocytes in leukocyte lipopolysaccharide responses.

Authors:  Ian Sabroe; Elizabeth C Jones; Lynne R Usher; Moira K B Whyte; Steven K Dower
Journal:  J Immunol       Date:  2002-05-01       Impact factor: 5.422

6.  Selective roles for Toll-like receptor (TLR)2 and TLR4 in the regulation of neutrophil activation and life span.

Authors:  Ian Sabroe; Lynne R Prince; Elizabeth C Jones; Malcolm J Horsburgh; Simon J Foster; Stefanie N Vogel; Steven K Dower; Moira K B Whyte
Journal:  J Immunol       Date:  2003-05-15       Impact factor: 5.422

7.  Macrophage migration inhibitory factor up-regulates the expression of interleukin-8 messenger RNA in synovial fibroblasts of rheumatoid arthritis patients: common transcriptional regulatory mechanism between interleukin-8 and interleukin-1beta.

Authors:  Shin Onodera; Jun Nishihira; Yoshikazu Koyama; Tokifumi Majima; Yoshimitsu Aoki; Hiroki Ichiyama; Teruo Ishibashi; Akio Minami
Journal:  Arthritis Rheum       Date:  2004-05

8.  Toll-like receptor (TLR)2 and TLR4 agonists regulate CCR expression in human monocytic cells.

Authors:  Lisa C Parker; Moira K B Whyte; Stefanie N Vogel; Steven K Dower; Ian Sabroe
Journal:  J Immunol       Date:  2004-04-15       Impact factor: 5.422

9.  Control of fibroblast-like synoviocyte proliferation by macrophage migration inhibitory factor.

Authors:  Derek Lacey; Annaleise Sampey; Robert Mitchell; Richard Bucala; Lanie Santos; Michelle Leech; Eric Morand
Journal:  Arthritis Rheum       Date:  2003-01

10.  Macrophage migration inhibitory factor (MIF) regulates host responses to endotoxin through modulation of Toll-like receptor 4 (TLR4).

Authors:  Thierry Roger; Céline Froidevaux; Christian Martin; Thierry Calandra
Journal:  J Endotoxin Res       Date:  2003
View more
  6 in total

Review 1.  Mechanisms of macrophage migration inhibitory factor (MIF)-dependent tumor microenvironmental adaptation.

Authors:  Beatriz E Rendon; Sharon S Willer; Wayne Zundel; Robert A Mitchell
Journal:  Exp Mol Pathol       Date:  2009-01-07       Impact factor: 3.362

2.  Macrophage migration inhibitory factor regulates interleukin-6 production by facilitating nuclear factor-kappa B activation during Vibrio vulnificus infection.

Authors:  Chia-Chang Chuang; Yin-Ching Chuang; Wen-Teng Chang; Chi-Chung Chen; Lien-I Hor; A-Ming Huang; Pui-Ching Choi; Chi-Yun Wang; Po-Chin Tseng; Chiou-Feng Lin
Journal:  BMC Immunol       Date:  2010-10-12       Impact factor: 3.615

3.  Temporal interleukin-1beta secretion from primary human peripheral blood monocytes by P2X7-independent and P2X7-dependent mechanisms.

Authors:  Jon R Ward; Peter W West; Mark P Ariaans; Lisa C Parker; Sheila E Francis; David C Crossman; Ian Sabroe; Heather L Wilson
Journal:  J Biol Chem       Date:  2010-05-21       Impact factor: 5.157

4.  Macrophage migration inhibitory factor antagonist (S,R)3‑(4‑hydroxyphenyl)‑4,5‑dihydro‑5‑isoxazole acetic acid methyl ester attenuates inflammation and lung injury in rats with acute pancreatitis in pregnancy.

Authors:  Yu Zhou; Liang Zhao; Fangchao Mei; Yupu Hong; He Xia; Teng Zuo; Youming Ding; Weixing Wang
Journal:  Mol Med Rep       Date:  2018-03-01       Impact factor: 2.952

5.  Urinary macrophage migration inhibitory factor serves as a potential biomarker for acute kidney injury in patients with acute pyelonephritis.

Authors:  Ming-Yuan Hong; Chin-Chung Tseng; Chia-Chang Chuang; Chia-Ling Chen; Sheng-Hsiang Lin; Chiou-Feng Lin
Journal:  Mediators Inflamm       Date:  2012-12-23       Impact factor: 4.711

6.  ISO-66, a novel inhibitor of macrophage migration, shows efficacy in melanoma and colon cancer models.

Authors:  Kyriaki Ioannou; Kai Fan Cheng; Gregg V Crichlow; Anastasios I Birmpilis; Elias J Lolis; Ourania E Tsitsilonis; Yousef Al-Abed
Journal:  Int J Oncol       Date:  2014-07-22       Impact factor: 5.650

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.